Pediatrix Medical Group, Inc. (NYSE:MD) Shares Acquired by Principal Financial Group Inc.

Principal Financial Group Inc. grew its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 14.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 513,618 shares of the company’s stock after purchasing an additional 63,581 shares during the period. Principal Financial Group Inc. owned about 0.60% of Pediatrix Medical Group worth $5,953,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. nVerses Capital LLC acquired a new position in shares of Pediatrix Medical Group in the second quarter worth about $31,000. Innealta Capital LLC purchased a new position in Pediatrix Medical Group during the 2nd quarter worth approximately $33,000. Nisa Investment Advisors LLC raised its stake in Pediatrix Medical Group by 47.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock valued at $36,000 after purchasing an additional 1,524 shares during the period. Canada Pension Plan Investment Board purchased a new stake in shares of Pediatrix Medical Group in the second quarter valued at $72,000. Finally, CWM LLC boosted its position in shares of Pediatrix Medical Group by 134.0% in the third quarter. CWM LLC now owns 6,427 shares of the company’s stock worth $74,000 after buying an additional 3,681 shares during the period. Institutional investors and hedge funds own 97.71% of the company’s stock.

Wall Street Analyst Weigh In

MD has been the subject of several research analyst reports. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, November 13th. UBS Group raised their price target on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a “neutral” rating in a report on Tuesday, November 5th. Truist Financial upped their price objective on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Mizuho lifted their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research note on Tuesday. Finally, Jefferies Financial Group upped their price target on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $16.10.

Pediatrix Medical Group Stock Down 0.8 %

MD stock opened at $14.49 on Thursday. The firm has a market cap of $1.24 billion, a PE ratio of -4.74, a PEG ratio of 2.03 and a beta of 1.55. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $16.41. The company has a fifty day simple moving average of $12.77 and a 200 day simple moving average of $9.96. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.83.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings data on Friday, November 1st. The company reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. The business had revenue of $511.20 million for the quarter, compared to analyst estimates of $498.87 million. During the same quarter in the prior year, the firm posted $0.29 EPS. The firm’s revenue for the quarter was up .9% on a year-over-year basis. Sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 1.25 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Laura A. Linynsky sold 7,000 shares of Pediatrix Medical Group stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $11.16, for a total transaction of $78,120.00. Following the sale, the director now directly owns 30,805 shares of the company’s stock, valued at $343,783.80. This trade represents a 18.52 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Mary Ann E. Moore sold 8,108 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $16.00, for a total value of $129,728.00. Following the completion of the transaction, the executive vice president now directly owns 135,810 shares of the company’s stock, valued at approximately $2,172,960. This trade represents a 5.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 53,808 shares of company stock valued at $751,277 in the last quarter. Insiders own 2.00% of the company’s stock.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.